Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.875 GBX | +7.63% | +11.58% | +19.84% |
Apr. 10 | FTSE 100 Closes Up 0.3% as U.S. Uncertainty Boosts Appetite for U.K. Stocks | DJ |
Apr. 10 | E-Therapeutics says company faces lack of interest as UK listing | AN |
Business Summary
Number of employees: 34
Sales per Business
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drug Discovery
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -0.42% |
Sales per region
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United Kingdom
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -0.42% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ahmad Mortazavi
CEO | Chief Executive Officer | 53 | 20-01-31 |
Director of Finance/CFO | - | - | |
Alan Whitmore
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | - | 20-04-01 | |
Director/Board Member | 68 | 20-02-10 | |
Alison Gallafent
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Trevor Jones
CHM | Chairman | 82 | 15-10-27 |
Director/Board Member | 68 | 20-02-10 | |
Ahmad Mortazavi
CEO | Chief Executive Officer | 53 | 20-01-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 584,335,487 | 237,003,079 ( 40.56 %) | 0 | 40.56 % |
Company contact information
e-Therapeutics Plc
Paddington Central 4 Kingdom Street
W2 6BD, London
+44 20 4551 8888
http://www.etherapeutics.co.ukSector
1st Jan change | Capi. | |
---|---|---|
+19.84% | 67.29M | |
+0.47% | 42.86B | |
+11.66% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.54% | 25.15B | |
-24.23% | 18.63B | |
+27.68% | 12.37B | |
-3.19% | 11.92B | |
+7.02% | 11.21B |
- Stock Market
- Equities
- ETX Stock
- Company e-therapeutics plc